Please select the option that best describes you:

What dose-fractionation would you utilize for an unresectable localized cutaneous melanoma that has progressed on immunotherapy?  

Specifically, for a melanoma of the axilla with proximity to the brachial plexus, how would you approach such a case to minimize chance of radiation-induced brachial plexopathy?



Answer from: Radiation Oncologist at Academic Institution